Related Experiment Video
Updated: Jul 20, 2025

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
Published on: April 28, 2022
Flanking regions, amyloid cores, and polymorphism: the potential interplay underlying structural diversity
Anukool A Bhopatkar1, Rakez Kayed1
1Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, USA; Departments of Neurology, Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, Texas, USA.
Protein structure variations, known as polymorphs, can influence neurodegenerative disease progression. This review explores how flanking regions of amyloid cores may induce these polymorphs, offering potential therapeutic targets.
Area of Science:
- Biochemistry
- Neuroscience
- Structural Biology
Background:
- Amyloid cores, rich in β-sheets, define protein aggregates in neurodegenerative diseases.
- The same protein sequence can form diverse amyloid structures (polymorphs).
- These structural variants are linked to distinct disease pathologies and phenotypes.
Purpose of the Study:
- To review the role of flanking regions in inducing amyloid polymorphism.
- To explore how flanking regions' disordered nature contributes to conformational diversity.
- To identify potential therapeutic strategies targeting these regions.
Main Methods:
- Literature review focusing on amyloid polymorphism.
- Analysis of flanking regions in well-characterized proteins (amyloid-β, α-synuclein, Tau, TDP-43).
- Discussion of factors influencing aggregate structure.
Main Results:
- Flanking regions adjacent to amyloid cores are often disordered.
- This disorder provides functional promiscuity, enabling conformational polymorphism.
- Polymorphism in amyloid-β, α-synuclein, Tau, and TDP-43 is influenced by these regions.
Conclusions:
- Flanking regions are key players in the generation of amyloid polymorphs.
- Understanding these regions is crucial for developing targeted therapies.
- Modulating flanking region properties offers a novel therapeutic avenue for neurodegenerative disorders.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Protein Folding
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Protein Organization
Structural Protein Function
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

